Clinical Trial Update: M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for M7824 (MSB0011359C) in combination with gemcitabine in adults with previously treated advanced pancreatic adenocarcinoma; study phases…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• M7824 (MSB0011359C) (MSB0011359C)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cancer of Pancreas, Pancreas Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-06-16